University of Grenoble
Also known as: AGDUC - Grenoble | Cardiac Surgery Department - University Hospital of Grenoble, | Centre d'Investigation Clinique de Grenoble CIC1406 | CHU de Grenoble Alpes | CHU de Grenoble - Hopital de la Tronche | CHU DE GRENOBLE - LA TRONCHE | CHU Grenoble | chu gRENOBLE aLPES | CHU Grenoble - Alpes | CHU Grenoble GOELAMS | CHU Grenoble - La Tronche | CHU of Grenoble | CIC, CHU Grenoble | GIPSA-LAB | Grenoble Alpes University Hospital, HP2 laboratory - INSERM U1042 and Grenoble Alpes University | Grenoble (FR), University College Hospital | Grenoble Hospital University | Groupe Hospitalier Mutualiste de Grenoble | Hopital Michalon , CHU de Grenoble | Hospital University Grenoble | INSERM + University Hospital Grenoble | Internal Medicine - University Hospital Grenoble-Alpes | Medical University of Grenoble | Nephrology Dialysis Transplantation/ CHU GRENOBLE | Pneumology Department, University Hospital of Grenoble | University Grenoble Alps | University Grenoble Hospital | University Hospital Grenoble | University Hospital, Grenoble | University Hospital Grenoble-Alpes | University Hospital, Grenoble Alpes, FRANCE | University Hospital of Genoble | University Hospital of Grenoble | University Hospital of Grenoble, France
Highest phase reached
Phase 4
First clinical trial
May 1, 1987Last known activity
Jun 30, 2025
Timeline
1330s
- Jan 1, 1339
University of Grenoble— Founded
Drugs by trial phase (159 distinct, 131 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (60 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (32 own, 0 via acquisition)
Indications
Studied for
- Adrenal Insufficiency
- Anxiety Disorders
- Aortic Dissection
- Apnea
- Asthenia
- Atherosclerosis
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Breast Neoplasms
- Bronchiolitis
- Brugada Syndrome
- Candidiasis
- Candidiasis, Invasive
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Craniocerebral Trauma
- Cytomegalovirus Infections
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Emergencies
- Encephalitis
- Encephalitis, Herpes Simplex
- Endocrine System Diseases
- Epilepsy
- Foot Ulcer
- Glioma
- Glucose Metabolism Disorders
- Heart Failure
- Hemorrhage
- Herpes Simplex
- Hyperkalemia
- Hyperlactatemia
- Hypertension
- Hypovolemia
- Hypoxia
- Infections
- Inflammation
- Inflammatory Bowel Diseases
- Insulin Resistance
- Intestinal Diseases
- Intracranial Hypertension
- Ischemia
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Diseases, Obstructive
- Lymphoma
- Lymphoma, Mantle-Cell
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Major Depressive Disorder
- Melanoma
- Meniere Disease
- Meningeal Carcinomatosis
- Meningitis
- Metabolic Diseases
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Optic Nerve Diseases
- Optic Neuropathy, Ischemic
- Pancreatic Neoplasms
- Parkinson Disease
- Pneumonia
- Postoperative Pain
- Preleukemia
- Procedural Pain
- Prostatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Raynaud Disease
- Recurrence
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Retinal Neoplasms
- Retinoblastoma
- Sciatica
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Seizures
- Shock, Hemorrhagic
- Skin Ulcer
- Sleep Apnea, Central
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Stroke
- Syndrome
- Thoracic Injuries
- Thrombocytopenia
Recent trials (50)
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06638710Lead sponsorPhase 2Nov 1, 2024
- NCT06582186Lead sponsorPhase 4Oct 31, 2024
- NCT06611891Lead sponsorPhase 3Oct 31, 2024
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06311604Lead sponsorN/AJun 20, 2024
- NCT06311604OfficialN/AJun 20, 2024
- NCT06212765Lead sponsorPhase 3Jan 25, 2024
- NCT05512403Overall official - principal investigatorPhase 3Jan 30, 2023
- NCT05448677Overall official - principal investigatorPhase 2Dec 15, 2022
- NCT05448677Lead sponsorPhase 2Dec 15, 2022
- NCT05546879Overall official - principal investigatorPhase 1Nov 30, 2022
- NCT05546853Lead sponsorPhase 1Nov 30, 2022
- NCT05546879Lead sponsorPhase 1Nov 30, 2022
- NCT05546853Overall official - principal investigatorPhase 1Nov 30, 2022
Details
- Founded
- Grenoble, FR Jan 1, 1339
- Last known activity
- Jun 30, 2025
Notes
New name: Université Grenoble Alpes